Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00178152 · ClinicalTrials.gov registry record
Erythema Toxicum Neonatorum in Newborns and the Development of Asthma
A clinical trial, sponsored by University of Rochester.
- Completed
- Registry status
- 334
- Enrollment target
NCT00178152: Completed study, sponsored by University of Rochester.
NCT00178152 is a clinical trial that has completed, run by University of Rochester. The registered enrollment target is 334 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00178152 has completed, sponsored by University of Rochester.
- COMPLETED
- Registry status
- 334 participants
- Enrollment target
Study Summary
Erythema Toxicum Neonatorum (ETN) is a common skin finding that affects healthy full-term babies. Several authors have commented on the possible relationship between ETN and the development of atopic conditions, such as atopic dermatitis or respiratory disease later in life. There is a paucity of research addressing this issue.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 334 participants |
| Start Date | 2005-05 |
| Est. Completion | 2005-11 |
What the finished NCT00178152 record still lists
NCT00178152 is an observational study that tracks outcomes without assigning an intervention. The registered 334 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT00178152 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00178152 about?
NCT00178152 is a clinical study titled "Erythema Toxicum Neonatorum in Newborns and the Development of Asthma". Erythema Toxicum Neonatorum (ETN) is a common skin finding that affects healthy full-term babies. Several authors have commented on the possible relationship between ETN and the development of atopic conditions, such as atopic dermatitis or respiratory disease later in life. There is a paucity of re...
What is the current status of trial NCT00178152?
This trial is currently completed. The enrollment target is 334 participants. The study started on 2005-05. Estimated completion is 2005-11.
Who is sponsoring clinical trial NCT00178152?
This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05131672 · 334 participants · NA
Cast or Operation for Medial Epicondyle Fracture Treatment in Children
- NCT05131685 · 334 participants · NA
Distal Radius Interventions for Fracture Treatment
- NCT05546931 · 334 participants · NA
Mobile Health Program for Rural Hypertension
- NCT05722197 · 334 participants · NA
Assessment of Emotion Regulation Strategies Used When Suicidal
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia